DYN

DYNE THERAPEUTICS INC

DYN·26818M108·US·Common Stock·Healthcare - Biotechnology-13D/G

DYN (DYNE THERAPEUTICS INC) is held by 122 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($247.4M), BlackRock, Inc. ($212.1M), FMR LLC ($161.5M). Net institutional sentiment: Mixed.

122
Holders
(10 Elite)
$1.7B
Total Value
60% (134)
Consensus
80 buying - 54 selling
13F: Insider & Congress:
DYN

Smart Money Verdict

View all
Held by 122 funds
10 elite

Who's Trading

InsiderRPRhodes Jason PSell $2.9MJul 7, 2026
InsiderRPRhodes Jason PSell $699KJul 7, 2026
InsiderRPRhodes Jason PSell $1.4MJul 7, 2026
InsiderRPRhodes Jason PSell $351KJul 7, 2026
InsiderRPRhodes Jason PSell $1.1MJul 7, 2026
InsiderRPRhodes Jason PSell $276KJul 7, 2026
InsiderRPRhodes Jason PSell $118KJul 7, 2026
InsiderRPRhodes Jason PSell $5.8MJul 6, 2026
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC8.3%May 15, 2026
ActivistTRT. Rowe Price Investment Management, Inc.18.7%May 15, 2026

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
13.6M(-1.7%)$247.4M0.1%+14.03%
0
Increased
11.7M(+4.5%)$212.1M0.0%+13.35%
32
Increased
8.9M(+35.6%)$161.5M0.0%+16.82%
39
Increased
6.8M(+40.8%)$122.6M0.5%+33.38%
57
Decreased
6.7M(-0.6%)$120.6M0.0%+28.81%
0
New
6.4M$116.1M0.0%+63.22%
42
New
4.2M$75.5M0.0%+63.22%
41
Increased
3.5M(+7.4%)$63.5M0.0%+23.88%
32
Decreased
3.3M(-8.3%)$55.6M0.0%+99.09%
0
Increased
2.3M(+0.2%)$42.2M0.0%+0.43%
29
Increased
2M(+0.1%)$36.4M0.0%+48.11%
29
Decreased
1.7M(-24.5%)$31.2M0.0%+48.47%
0
Increased
1.4M(+63.5%)$26.2M0.0%+67.77%
42
Increased
1.4M(+29.1%)$25.9M0.0%+56.86%
36
New
1.4M$25M0.1%+63.22%
40
Increased
1.4M(+7.1%)$24.6M0.1%+46.78%
31
Increased
1.2M(+9.8%)$21.7M0.0%+24.22%
31
Increased
1.2M(+0.6%)$21M0.0%+23.00%
29
Decreased
1M(-80.7%)$18.1M0.0%+86.47%
0
Increased
951,589(+870.3%)$17.2M0.0%+58.09%
46

Showing 1-20 of 140

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used